Genentech To Increase Diversity In Clinical Trials

NEW YORK - Genentech, perhaps the most successful biotech company, is dipping a toe into one of the biggest questions in medicine: How do you study whether drugs work differently based on gender, ethnicity or economic status? A $5 million, four-year research effort with the Baylor College of Medicine in Houston will aim to begin to answer why some groups of people don't enter clinical trials often enough--potentially sabotaging the research process. The project will be discussed Tuesday at the annual meeting of the Biotechnology Industry Organization.

Back to news